Sunday, April 21, 2024
HomeBharat NewsMaharashtraMoU Signed For Commercial Production Of Indigenously Developed Vaccine “Lumpi-Provac”.

MoU Signed For Commercial Production Of Indigenously Developed Vaccine “Lumpi-Provac”.

Last updated on July 18th, 2023 at 03:56 pm

Estimated reading time: 3 minutes

An MoU for the production of the Goat Pox Vaccine and “Lumpi-Provac” Vaccine was signed in Nagpur on December 29, 2022, in the presence of Shri Parshottam Rupala, Union Minister for Fisheries, Animal Husbandry and Dairying, Chief Minister and Deputy CM of Maharashtra.

Shri Rupala appreciated the commendable effort made by ICAR in developing Lumpi-Provac, an indigenous vaccine for LSD. He further added that this MoU will also ensure large-scale production of Goat Pox Vaccine for the future needs of India’s livestock sector. The goat pox vaccine is currently used to control lumpy dermatitis in cattle and has been shown to be effective against lumpy.

He further highlighted the relevance of the technology and requested IVBP, Pune to start manufacturing the vaccine on a large scale without any further delay so that the vaccine could be made available for use by the department to help farmers in overcoming the disease.

Developed a homologous live-attenuated LSD vaccine in collaboration with National Center for Veterinary Type Culture, ICAR-National Research Center on Equine (ICAR-NRCE), Hisar (Haryana), ICAR-Indian Veterinary Research Institute (IVRI), Izatnagar (UP) Did. , named Lumpi-ProVacInd. Agrinovate India Limited (AgIn), the commercial arm of DARE, Ministry of Agriculture & Farmers Welfare, Govt.

The Government of India today granted “non-exclusive rights” for commercial production of “Lumpi-Provac” to the Institute of Veterinary Biological Products (IVBP), Pune.

Lumpi-ProVacind is safe in animals and induces an LSDV-specific antibody- and cell-mediated immune response, in addition to providing complete protection against lethal LSDV challenge. Lumpi-ProVacind is used for prophylactic vaccination of animals against lumpy skin disease, which is illegal protection for about one year.

One dose of the vaccine contains 103.5 TCID50 of live-attenuated LSDV (Ranchi strain). The vaccine is stored at 4°C. The vaccine should be shipped on ice and used within a few hours after reconstitution. The patent has been filed for the technology by ICAR.

The program was presided over by Shri Purushottam Rupala, Union Minister for Fisheries, Animal Husbandry and Dairying. of India, Shri Eknath Shinde, Chief Minister, Govt. of Maharashtra, Shri Devendra Fadnavis, Deputy Chief Minister, Govt. of Maharashtra, Shri Radhakrishna Vikhe Patil, Minister of Animal Husbandry, Govt. Maharashtra’s Dr. B.N. Tripathi, DDG (Animal Science), ICAR, Dr. Triveni Dutt, Director, ICAR-IVRI, Dr. TK Bhattacharya, Director, ICAR-NRCE, Shri Sachindra Pratap Singh, Commissioner (AH), Govt. of Maharashtra and Dr. Praveen Malik, CEO, AgIn, ICAR, and other officials from AgIn. Agrinovate granted a non-exclusive license to IVBP, Pune for ten years.

Google News

Latest Stories

RELATED ARTICLES
- Advertisment - NIT Infotech